Related Experiment Video
Updated: May 21, 2026

A High-throughput Method for Measurement of Glomerular Filtration Rate in Conscious Mice
Published on: May 10, 2013
[Glomerular filtration rate: which formula should be used in patients with myocardial infarction?]
Sérgio Barra1, Rui Providência, Joana Silva
1Serviço de Cardiologia, Centro Hospitalar e Universitário de Coimbra, Hospital Geral, Coimbra, Portugal. sergioncbarra@gmail.com
Insights
The Modification of Diet in Renal Disease (MDRD) formula more accurately predicts coronary artery disease severity and cardiovascular risk in myocardial infarction (MI) patients than the Cockcroft-Gault (CG) formula. MDRD GFR is a valuable tool for assessing risk in these patients.
Area of Science:
- Cardiology
- Nephrology
- Clinical Risk Assessment
Background:
- Assessing renal dysfunction in myocardial infarction (MI) patients is crucial but methods vary.
- Glomerular filtration rate (GFR) is a key indicator of kidney function.
- Disagreement exists on the optimal GFR formula for predicting outcomes in MI patients.
Purpose of the Study:
- To compare the predictive accuracy of two GFR formulas: Cockcroft-Gault (CG) and Modification of Diet in Renal Disease (MDRD).
- To evaluate their ability to predict coronary artery disease (CAD) extent and cardiovascular risk in MI patients.
Main Methods:
- A cohort of 452 MI patients admitted to a cardiac ICU was studied.
- GFR was estimated using both CG and MDRD formulas.
- Patients were followed for two years to assess CAD extent, in-hospital mortality, and cardiovascular events.
Main Results:
- MDRD-estimated GFR <60ml/min/1.73 m(2) was associated with more extensive CAD and significantly higher two-year mortality, reinfarction, decompensated heart failure (DHF), and combined cardiovascular endpoints.
- CG-estimated GFR <60ml/min/1.73 m(2) only predicted higher DHF risk.
- Both formulas predicted in-hospital mortality.
Conclusions:
- GFR estimation is valuable for predicting cardiovascular endpoints in MI patients.
- The MDRD formula demonstrated superior accuracy compared to the CG formula in predicting CAD severity and two-year cardiovascular risk.
- MDRD is recommended for assessing renal dysfunction and cardiovascular risk in MI patients.
Introduction:
There is disagreement regarding the best method for assessing renal dysfunction in patients with myocardial infarction (MI). This study aims to compare two commonly used formulas for measuring glomerular filtration rate (GFR) (Cockcroft-Gault [CG] and modification of diet in renal disease [MDRD]) in terms of predicting extent of coronary artery disease (CAD) and short- and long-term cardiovascular risk.
Methods:
We studied 452 patients admitted to a cardiac intensive care unit (ICU) with MI (age 69.01±13.64 years; 61.7% male, 38.5% diabetic) and followed for two years. CG and MDRD GFR estimates were compared in terms of prediction of CAD extent, in-hospital mortality risk and cardiovascular risk during follow-up.
Results:
GFR <60ml/min/1.73 m(2) using the MDRD formula was associated with a tendency for more extensive CAD (2.70 affected segments vs. 2.20, p=0.052) and higher two-year mortality risk (p<0.001, OR 3.84, 95% CI 2.04-7.22) and risk for reinfarction (p<0.001, OR 4.09, 95% CI 2.00-8.39), decompensated heart failure (DHF) (p<0.001, OR 3.95, 95% CI 2.04-7.66) and combined cardiovascular endpoints (p=0.001, OR 2.47, 95% CI 1.47-4.17). Using the CG formula, GFR<60ml/min/1.73 m(2) only predicted higher risk for DHF (p=0.016, OR 4.5, 95% CI 1.11-16.57), despite a tendency for more overall combined cardiovascular endpoints (p=0.09, OR 2.84). Both formulas predicted in-hospital mortality.
Discussion/Conclusions:
This study confirmed the value of GFR in predicting various cardiovascular endpoints in patients with MI. Compared to the CG formula, the MDRD formula was significantly more accurate in predicting the severity of CAD and two-year CV risk in patients admitted to the ICU with MI.
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Renal Clearance
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Renal Drug Excretion: Glomerular Filtration
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles.

